Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederjamanetwork.com
JAMA Current Issue
Get the latest updates from JAMA Current Issue directly as they happen.
Follow now 594 followers
Latest posts
Last updated 1 day ago
Biomarker-Based Eligibility for Lung Cancer Screening
1 day ago
This study aims to develop and validate a protein-based risk model in...
Hearing Aids for Adults With Mild to Moderate Hearing Loss
1 day ago
This JAMA Insights discusses hearing aids for adults with mild to moderate...
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease Research Summary
1 day ago
This study investigated whether low-dose rivaroxaban reduces major adverse cardiovascular events compared...
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease
1 day ago
This randomized clinical trial examines the safety and efficacy of low-dose rivaroxaban...
Rivaroxaban for Cardiovascular Disease Prevention in Chronic Kidney Disease
1 day ago
Cardiovascular disease accounts for approximately half of all deaths among patients with...
When Patients Share Everything With An AI Chatbot
1 day ago
This Viewpoint discusses the potential benefits and risks, such as privacy violations...
Patient Information: Adults With Mild to Moderate Hearing Loss
1 day ago
This JAMA Patient Page describes the potential consequences of hearing loss in...
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer Research Summary
1 day ago
This study assessed whether adding ivonescimab, a bispecific antibody, to chemotherapy improves...
Farther, Faster, and More Often
1 day ago
In this narrative medicine essay, a retired internal medicine physician’s lap swimming...
Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer
1 day ago
This randomized trial assesses the effect of ivonescimab added to chemotherapy on...
Review of Type 1 Diabetes—Reply
1 day ago
In Reply We thank the Letter authors for their thoughtful responses to...
Review of Type 1 Diabetes
1 day ago
To the Editor A recent Review of type 1 diabetes reported that...